Abstract We have characterized a newly generated mouse model of obesity, a mouse strain deficient in all five previously described leptin receptor isoforms. These transgenic mice, named the db 333 /db 333 mice, were identified from an ENU mutagenesis screen and carry a point mutation in the seventh exon of the db gene encoding the leptin receptor, resulting in a premature stop codon (Y 333 Stop) and gene product that lacks STAT signaling domains. db 333 /db 333 mice have a morbidly obese phenotype, with body weights diverging from wild type as early as 4 weeks of age (P \ 0.05). To determine the contribution of the short isoforms of the leptin receptor in this metabolic phenotype, we performed an extensive metabolic characterization of the db 333 /db 333 mouse in relation to the well-characterized db/db mouse lacking only the long form of the leptin receptor. db 333 /db 333 mice have similar endocrine and metabolic parameters as previously described in other leptin receptor transgenic mice including db/db mice that lack only the long isoform of the leptin receptor. However, db 333 /db 333 mice show a subtle trend toward higher body weight and insulin levels, lower oxygen, carbon dioxide production, respiratory exchange ratio (RER), and temperature than db/db mice suggesting the short isoforms may play an additional role in energy homeostasis.
Introduction
Leptin signaling is an important mediator of feeding behavior, energy homeostasis, and normal immune and reproductive functions (Halaas et al. 1995; Pelleymounter et al. 1995; Chehab et al. 1996; Schwartz et al. 1996; Loffreda et al. 1998; Lord et al. 1998) . Leptin is a 16 kDa cytokine, secreted by adipocytes that is encoded by the ob gene that acts at the hypothalamic level through the leptin receptor (Ob-R) encoded by the db gene. Leptin acts as a feedback signal reflecting the nutritional status of the periphery to suppress feeding and to permit neuroendocrine functions (Ahima et al. 1996 Heiman et al. 1997; Yu et al. 1997 ). Conversely, negative energy balance decreases leptin levels, increasing the drive to feed triggering neuroendocrine responses that limit energy expenditure (Ahima et al. 1996; Bates and Myers 2003) .
Leptin deficient (ob/ob) and leptin receptor deficient (db/db) mouse models have provided many insights into leptin signaling. Deficiency in leptin signaling causes a disruption in energy balance resulting in obesity from hyperphagia and decreased energy expenditure followed by the spontaneous development of insulin resistance (Ingalls et al. 1950; Zhang et al. 1994; Pelleymounter et al. 1995; Frederich et al. 1995; Chua 1997) . A similar phenotype is observed in humans with very rare mutations in the leptin or leptin receptor genes (Montague et al. 1997; Farooqi et al. 2002; Farooqi and O'Rahilly 2006) . With the exception of humans with this rare genetic leptin deficiency circulating leptin levels are positively correlated with adiposity (Frederich et al. 1995) . Obese individuals have elevated circulating leptin levels, but leptin fails to mediate weight loss, suggesting that most human obesity is a form of leptin resistance.
The leptin receptor (Ob-R) belongs to the cytokine receptor class I superfamily (Tartaglia 1997) , and in the mouse the receptor is alternatively spliced into five known isoforms: Ob-Ra, Ob-Rb, Ob-Rc, Ob-Rd, and Ob-Re (Lee et al. 1996) . The longest isoform (Ob-Rb) is expressed at a high level in the hypothalamus and at a low level in other tissues including testes, adipose tissues, pancreatic b cells, heart, lung, and lymph nodes (Ghilardi et al. 1996; Lee et al. 1996; Emilsson et al. 1997; Fei et al. 1997; Lollmann et al. 1997; Spanswick et al. 1997) . The Ob-Rb form is highly conserved among species and possesses an intracellular cytoplasmic domain of *300 residues (Chen et al. 1996; Lee et al. 1996; Chua et al. 1997; Tartaglia 1997) . Ob-Rb, like other members of the cytokine receptor family mediates tyrosine kinase signaling by means of associated Janus kinase (Jak)/signal transducers and activators of transcription (STAT) pathway. Ob-Ra, Ob-Rc, Ob-Rd, and Ob-Re are considered 'short isoforms', since they lack the long cytoplasmic domain. Ob-Ra-d contain identical extracellular leptin-binding and transmembrane domains, as well as the same first 29 intracellular amino acids and diverge in sequence secondary to alternative splicing of 3 0 exons (Chua et al. 1996) . The short isoform Ob-Ra is ubiquitously expressed (Lollmann et al. 1997 ) with particularly high expression in the choroid plexus and microvessels in the CNS and has been suggested to play a role in the transport of leptin across the blood brain barrier (Golden et al. 1997; Tartaglia 1997; Wu-Peng et al. 1997) . Ob-Re is a secreted isoform (Tartaglia 1997 ) that forms a complex with circulating leptin suggested to act as a buffering system to regulate leptin availability (Lollmann et al. 1997; Ge et al. 2002) . The other functions of the short isoforms of the leptin receptor have yet to be determined.
The db/db mouse has a mutation in the signaling C terminus of the leptin receptor gene that results in a nonfunctional, truncated long form of Ob-Rb (Hummel et al. 1966; Chen et al. 1996; Lee et al. 1996) . Central or peripheral administration of leptin in db/db mice has no effect on food intake or body weight (Halaas et al. 1995) . Since db/db mice express all the other short leptin receptor isoforms besides Ob-Rb, yet still develop the obese phenotype, it has been hypothesized that the weight-controlling effects of leptin in mice are mediated by signaling through the long leptin receptor isoform Ob-Rb.
Furthermore, leptin activation of STAT3 occurs only in wild type (WT) and ob/ob mice but not in db/db mice (Vaisse et al. 1996) . However, a recent study on leptin signaling showed that leptin stimulation of interleukin 1 beta (IL-1b) expression in the brain still occurs in db/db mice (Hosoi et al. 2002) . The possibility that leptin has effects in mice lacking the Ob-Rb isoform indicates that the short leptin receptor isoforms could play a yet undetermined role in leptin signaling.
In this present study, we have characterized a transgenic mouse model of obesity that lacks all known isoforms of the leptin receptor on a C57BL/6 background. These db 333 /db 333 mice were isolated from an ENU mutagenesis screen and have a T to A transversion in the seventh coding exon of the leptin receptor, causing a premature stop codon: Y 333 Stop. We performed an extensive endocrine and metabolic characterization of this transgenic mouse model of obesity in relation to the well characterized db/db mouse lacking just the long form of the leptin receptor.
Experimental Procedures

Animals and Surgery
Genetically obese C57BL/6 mice were generated in the laboratory of Dr. Bruce Beutler (The Scripps Research Institute, La Jolla, CA, USA) using ENU mutagenesis (Brown and Peters 1996) . Positional cloning was used to determine the location of the point mutation in the leptin receptor gene. Both male db 333 /db 333 and male WT littermates were fed ad libitum with mouse breeder diet composed of 11% fat, 17% protein, and 3.5% fiber (S-2335 Mouse Breeder, gross energy kcal 4.39 kcal/g). Lepr db / Lepr db on a C57BL/6 background (stock number 000697) were obtained from Jackson laboratories. Groups of five mice of each genotype were used in all experiments at the age of 6-8 months unless otherwise stated.
Mice were anesthetized with isofluorane (induction 3-5%, maintenance 1.0%) and implanted with transmitter devices (TA10TA-F20; Data Sciences, Arden Hills, MN) into the peritoneal cavity. Transmitter devices contain sensors that measure core body temperature (CBT) and locomotor activity. Mice were allowed to recover for 1 week and then submitted to a second surgery. After anesthesia (induction 3-5%, maintenance 0.9-1.5%), mice were placed into a stereotaxic apparatus. The skull was exposed, and holes were drilled to accommodate stereotaxic placement of a guide cannula (26 Ga, 1.0-cm length) aiming at the lateral ventricle (anterior-posterior from bregma, 0.3 mm; lateral, 1.0 mm; and ventral, 1.7 mm).
Mice with ad libitum access to food and water were monitored using a computer-controlled, open-circuit system (Oxymax System) that is part of an integrated Comprehensive Lab Animal Monitoring System (CLAMS; Columbus Instruments, Columbus, OH). Mice were singly housed in clear respiratory chambers (20 9 10 9 12.5 cm) with a stainless steel-elevated wire floor. Each of these chambers is equipped with a sipper tube delivering water and a food tray connected to a balance. Room air was passed through chambers at a flow rate of *0.5 l/min. Exhaust air from each chamber was sampled at 20-min intervals for 1 min. Sample air was sequentially passed through O 2 and CO 2 sensors (Columbus Instruments) for determination of O 2 and CO 2 content, from which measures of oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) are estimated. Outdoor air reference values are sampled after every 4 measurements. Gas sensors are calibrated prior to the onset of experiments with primary gas standards containing known concentrations of O 2 , CO 2 , and N2 (Airgas Puritan Medical, Ontario, CA). Respiratory exchange ratio (RER) was calculated as the ratio of VCO 2 to VO 2 . VO 2 , and VCO 2 are corrected for estimated effective metabolic mass per Kleiber's power function. Receiver plates (RPC-1; Data Sciences) positioned inside the chambers continuously monitored CBT and locomotor activity by means of a fully automated data acquisition system (Dataquest A.R.T., Data Sciences, Inc.). Mice were acclimated to the respiratory chambers for 4 days before the onset of study. Data are recorded under ambient room temperature clamped at 25°C, beginning from the onset of the dark cycle.
Genotyping
Genotyping of mice was carried out by PCR with 25 ng of genomic DNA isolated from tail clippings in 20 ll reaction mixtures containing 19 PCR buffer-Mg (Invitrogen), 0.2 mM each of a mixture of deoxynucleoside triphosphates (Invitrogen), 1.5 mM MgCl 2 (Invitrogen), 1 U of Taq DNA Polymerase (Invitrogen), and 0.5 lM of each primers db 333 / db 333 -F 5 0 -GCTGGAAGCCTGTCGTACTCTTCA-3 0 and db 333 /db 333 -R 5 0 -TACACTGCGTCATAGGTAAACTTCC CTC-3 0 . After an initial denaturation at 94°C for 3 min, 35 cycles of PCR at 94°C for 45 s, 55°C for 30 s, and 72°C for 1 min were performed, followed by a final extension at 72°C for 10 min. The PCR products were purified using a QIAquick PCR purification kit (Qiagen) and sequenced to identify homozygous mutant db 333 /db 333 mice.
Analysis of Fat Depots and Organ Weights
Mice were anesthetized with 5% isoflurane and subsequently killed. Wet fat pads (omental, mesenteric, subcutaneous, and brown adipose tissue) and the liver were weighed immediately.
Measurement of Food Intake in Response to Leptin
Mice were given leptin (Peprotech, Rocky Hill, NJ) injections (4 lg/ll, intracerebroventricular, icv) at 3:00 pm, prior to the onset of the dark cycle at 6:00 pm. An internal cannula (33 Ga, 1.1 cm length) connected to plastic tubing and a microsyringe (10 ll) was used for direct delivery into the lateral ventricle. A volume of 1.0 ll (leptin or heat inactivated leptin, 98°C for 30 min) was injected in a period of 5 min to allow for diffusion. Food intake was measured by weighing the amount of food eaten and normalized to initial body weight using the Kleiber's function of 0.75.
Measurement of Endocrine Parameters
Mice were anesthetized with 5% isoflurane and blood samples were collected via retro-orbital bleeds with EDTA coated capillary tubes (Drummond, Broomall, PA, USA) into EDTA coated vials (Microvette, Germany). Samples were spun down at 1,0009g for 10 min and plasma was stored at -80°C until analysis. Circulating levels of insulin, leptin, and IL-6 were determined using the mouse serum adipokine kit (Millipore, St. Charles, MO). Circulating levels of interleukin-1 receptor antagonist (IL-1Ra) were determined using the Immunoassay (R&D systems, Minneapolis, MN). All endocrine measurements were performed on plasma samples from mice at 6 months of age.
Insulin Tolerance Test
The glucose reducing effect of insulin injection was assessed in non-fasted mice. Baseline glucose levels are measured by withdrawing *0.6 ll of blood from the tail from unanesthetized mice before a load of human insulin was administered (1 unit/kg, i.p.; Sigma-Aldrich, St. Louis, MO). Further samples were collected 15, 30, 60, 90, and 120 min after the insulin challenge. Blood glucose levels (in mg per deciliter) were determined by a glucometer (Glucometer, Rite Aid).
Glucose Tolerance Test
Mice were fasted for 16 h overnight and injected intraperitoneally (i.p) with glucose (D-glucose, anhydrous; Sigma-Aldrich, St. Louis, MO) (1.5 mg/g body weight) in sterile water. Blood samples were taken before the glucose administration and then at 15, 30, 60, 90, and 120 min after injection. Blood glucose levels were determined by a glucometer (Glucometer, Rite Aid).
Data Analysis
The significance of the difference in values between db 333 /db 333 , db/db and WT mice was evaluated using a one way ANOVA followed by Tukey's honestly significant difference (HSD) test. For comparison of just db 333 /db 333 and WT mice a two-tailed independent T test was applied. The statistical significance was at the P \ 0.05 level. Data are expressed as means ± SE.
Results db 333 /db 333 Mice Lack All Leptin Receptor Isoforms Due to a Premature Stop Codon db 333 /db 33 mice were identified from an ENU mutagenesis screen and a positional cloning strategy was used to determine the location of the point mutation in the leptin receptor gene (Fig. 1a) . The specific mutation is a T to A transversion in the seventh coding exon, causing a premature stop codon: Y 333 Stop (TAT ? TAA). This premature stop codon causes biosynthesis of a truncated leptin receptor. Since the stop codon is upstream of the leptin receptor isoform splice sites, the mice lack earlier described long and short isoforms of the leptin receptor, see Fig. 1b b Schematic presentation of leptin receptor mutations in mouse models of obesity with leptin signaling deficiencies. The predicted protein length is shown with the numbers at the end of each receptor representing the amino acid residue at the carboxy terminus. The STAT-3 binding site is located at amino acid 1138 and has an important role in the regulation of energy balance through the JAK/ STAT signaling pathway 36.25 ± 1.70 g, P \ 0.05; Fig. 2b ). db 333 /db 333 mice have significantly increased quantities of omental, mesenteric and subcutaneous fat, brown adipose tissue (BAT), and higher liver mass than WT littermates (Fig. 2c) . db 333 /db 333 mice are hyperphagic and consume significantly more food than WT littermates throughout the 24 h monitoring period (Fig. 2d) , with the most significant increase in food intake in db 333 /db 333 mice in the dark cycle (db 333 /db 333 3.95 ± 0.12 g, WT 2.24 ± 0.05 g, P \ 0.05; Fig. 2e ). db 333 /db 333 mice had significantly elevated circulating levels of leptin, insulin, and IL-1Ra compared with WT littermates at 6 months of age (Table 1) . db 333 /db 333 mice also display significantly elevated insulin levels and show a trend toward higher IL-1Ra levels when compared with db/db mice. Levels of the pro-inflammatory cytokine interleukin 6 (IL-6) was also elevated in db 333 /db 333 and db/db mice relative to levels in WT, lean littermates. Measurements of O 2 production (VO 2 ) and CO2 production (VCO 2 ) were acquired from each metabolic chamber every 20 min and sent to a computer that collects and processes the data continuously over a 24 h monitoring period. Both db/db and db 333 /db 333 mice displayed significantly lower VO 2 (Fig. 7a ) and VCO 2 (Fig. 7b ) at all time points throughout both the light and dark cycle relative to lean mice (P \ 0.05). RER (VCO 2 /VO 2 ) in both db 333 /db 333 and db/db showed a trend of lower RER relative to WT mice that is most pronounced in the dark cycle indicating a trend to the use of lipids as energy substrates in Core body temperature and spontaneous locomotor activity in db 333 /db 333 , db/db, and WT mice during a 24 h monitoring period. a db 333 /db 333 and db/db mice display a significantly lower CBT relative to WT mice. b Average CBT over the 12 h light or dark cycle in db 333 /db 333 and db/db mice is significantly lower when compared with WT littermates. c Average spontaneous physical activity of db 333 /db 333 , db/db, and WT mice during a 24 h monitoring period.
db 333 /db 333 and db/db mice display decreased locomotor activity relative to WT mice. d Average activity for db 333 /db 333 , db/db, and WT mice during the light and dark cycle. Both db 333 /db 333 and db/db mice display lower average activity than WT mice. Data are plotted as mean ± SE for n = 4 animals of each genotype. Significant (P \ 0.05) differences between group means are denoted by asterisk and were determined by one way ANOVA and post hoc Tukey test
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Discussion
We have characterized a newly generated mouse model of obesity, the db 333 /db 333 mice, deficient in all known leptin receptor isoforms in mice. db 333 /db 333 mice have a point mutation in the seventh exon of the db gene encoding the leptin receptor resulting in a premature stop codon (Y 333 Stop) upstream of all the known splice sites. db 333 /db 333 mice have a morbidly obese phenotype, with body weights diverging from WT as early as 4 weeks of age. The obese phenotype of the db 333 /db 333 mice is caused not only by hyperphagia but also by disrupted neuroendocrine regulation of energy expenditure. db 333 /db 333 mice had significantly elevated circulating levels of leptin, insulin, and interleukin-1 receptor antagonist as also observed in human diabetics and mouse models of obesity (Ludvik et al. 1997; Luheshi et al. 1999; Meier et al. 2002; Juge-Aubry et al. 2003; Somm et al. 2005 Somm et al. , 2006 . This study describes an extensive in vivo metabolic comparison of the db 333 /db 333 mice lacking all forms of the leptin receptor with the db/db mice lacking just the Ob-Rb long isoform of the receptor (Chen et al. 1996) . The functional loss of leptin signaling in db 333 /db 333 and db/db mice was confirmed by icv administration of leptin that resulted in significant reduction in food intake in WT mice while, as expected, no significant appetite suppression was observed in db 333 /db 333 or db/db mice. Both db 333 /db 333 and db/db mice are obese, hyperphagic, and insulin resistant. The metabolic comparison of these obese leptin receptor deficient mice with lean mice showed that db 333 / db 333 and db/db mice consume significantly less O 2 and produce significantly less CO 2 in comparison with lean controls as observed in other obese mutants (Pelleymounter et al. 1995; Overton et al. 2001) . Neither db 333 /db 333 nor db/db mice display the classical circadian rhythm of lower oxygen demand and CO 2 production in the light cycle and markedly higher O 2 demand and CO 2 production in the dark cycle as seen in lean controls. The reduced RER in both db 333 /db 333 and db/db mice indicates the use of lipids as energy substrates in these mice as opposed to carbohydrates in WT mice as suggested by an RER closer to 1. The activity levels observed in db 333 /db 333 and db/db mice are dramatically reduced compared with WT animals. db 333 /db 333 and db/db mice also maintain a consistently lower CBT of *35°C consistent with previous findings in these Ob-Rb deficient mice (Trayhurn and James 1978; Harris et al. 2001 ). However, a modest increase in activity was observed in db 333 /db 333 mice relative to db/db mice toward the end of the dark cycle in comparison with db/db mice. This trend of increase in activity has previously been described in the s/s mutant mouse that has a Tyr to Ser mutation at position 1138 of the db gene that specifically disrupts the activation of the transcription factor STAT3 (Bates et al. 2004) . In both the db 333 /db 333 and s/s mutant mice, neither the CBT, VO 2 consumption nor CO 2 production was different from that observed in db/db mice at this time point, suggesting this modest increase in activity in the dark phase does not significantly alter overall energy expenditure.
Ob-Rb is believed to function through a Jak/STAT signal transduction pathway (Ghilardi et al. 1996) to promote fat oxidation (Hwa et al. 1996) , satiety (Satoh et al. 1998) , and the homeostasis of lipids (Unger et al. 1999) . Leptin signaling in hypothalamic neurons results in a decrease in feeding and an increase in energy expenditure in order to maintain energy homeostasis (Campfield et al. 1995; Halaas et al. 1995; Levin et al. 1996) . In states of negative energy balance such as starvation, a decrease in leptin levels causes an increase in food intake and a decrease in energy expenditure (Elmquist et al. 1998; Friedman and Halaas 1998) . Therefore, lack of the leptin signaling in these mice results in early onset obesity secondary to the increase in feeding and decreased energy utilization.
db 333 /db 333 mice have altered endocrine and metabolic parameters consistent with previously described leptin receptor deficient mouse models of obesity including db/db mice that lack only the Ob-Rb isoform (Chen et al. 1996; Myers 2004 ) and several other mutants described that lack all known isoforms of the leptin receptor (Aubert et al. 1985; Lee et al. 1997; Li et al. 1998 Fig. 6 Effects of icv leptin administration on food intake in db 333 /db 333 , db/db, and WT mice. Injection of leptin (icv 4 lg/ll) caused a significant reduction in food intake in WT mice (P = 0.0038) while no significant appetite suppression was observed in db 333 /db 333 or db/db mice. Data are plotted as mean ± SE for n = 4 animals of each genotype. Significant differences between group means are denoted by asterisk and were determined by one way ANOVA and post hoc Tukey test db 3J /db 3J mouse has a frameshift mutation at amino acid 625 (Leiter et al. 1980; Lee et al. 1997; Luo et al. 2006) and the db Pas /db Pas mouse has a duplication of exons 4 and 5 of Ob-R that introduces a premature stop codon at residue 281 (Li et al. 1998 ). Both mutations result in a truncated receptor without a transmembrane domain and result in complete ablation of all known leptin receptor splice variants (Fig. 1b) .
The db 333 /db 333 mice display very similar obese phenotypes to the other leptin receptor deficient mouse models of obesity. The C57BL/6 db 3J /db 3J mice gain weight in an identical manner to db 333 /db 333 mice, for example, at 12 weeks of age C57BL/6 db 3J /db 3J mice weigh 56 ± 7.4 g (Luo et al. 2006) (Aubert et al. 1985) .
The db 333 /db 333 and db/db mice display very similar metabolic phenotypes in this study. Therefore, this study further confirms the finding that the long cytoplasmic domain of the leptin receptor is the main isoform by which leptin exerts its effects on energy homeostasis (Ghilardi et al. 1996) . However, there is trend toward higher body weight, higher insulin and IL1-Ra levels; lower CO 2 , VO 2 , RER, and temperature in db 333 /db 333 mice when compared with db/db mice that raises the question whether the short forms of the receptor play an additional role in energy homeostasis. Transgenic replacement of the long form of the leptin receptor (Ob-Rb) WT db/db db333/db333 * * Fig. 7 Metabolic comparison of db 333 /db 333 , db/db, and WT mice during a 24 h monitoring period. a Oxygen consumption in db 333 / db 333 , db/db, and WT mice monitored for 24 h. Both db/db and db 333 / db 333 mice displayed similar oxygen consumption at all time points, and these obese mutants showed significantly lower oxygen consumption than WT mice throughout both the light and dark cycle. b CO 2 production in db 333 /db 333 , db/db, and WT mice monitored for 24 h. Both db/db and db 333 /db 333 mice displayed similar levels of CO 2 production at all time points, and these obese mutants showed significantly lower CO 2 production than WT mice throughout both the light and dark cycle. c RER (VCO 2 /VO 2 ) in db 333 /db 333 , db/db, and WT mice over a 24 h period. Both db 333 /db 333 and db/db show a trend of lower RER relative to WT mice that is most pronounced in the dark cycle. db 333 /db 333 mice show a consistently lower RER relative to db/ db and WT mice. Data are plotted as mean ± SE for n = 4 animals of each genotype. Significant (P \ 0.05) differences between group means are denoted by asterisk and were determined by one way ANOVA and post hoc Tukey test Cell Mol Neurobiol (2010) 30:23-33 31 impaired thermoregulatory thermogenesis phenotype (Kowalski et al. 2001 ). This partial attenuation of the obesity/ diabetes phenotype (including body weight, circulating leptin, glucose, and insulin) without a full restoration of WT levels may be reflective of a role of the shorter isoforms in energy homeostasis. In summary, we have characterized a novel transgenic mouse model of obesity, the db 333 /db 333 mice, with a mutation that ablates expression of all leptin receptor variants. This db 333 /db 333 mouse may prove useful in future studies on the roles of the long form and the short form of leptin receptors respectively.
